• OPEN AN ACCOUNT
Indian Indices
Sensex
78,542.44 43.27
( 0.06%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
66,870.65 1,263.94
(1.93%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Unjha Formulations Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
531762
INE576D01015
8.5780605
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
23.1
10.87
EPS(TTM)
Face Value()
Div & Yield %
1.05
10
0
 

unjha formulations ltd
Unjha Formulations reports standalone net loss of Rs 0.74 crore in the March 2026 quarter
May 18,2026
Net Loss of Unjha Formulations reported to Rs 0.74 crore in the quarter ended March 2026 as against net loss of Rs 0.41 crore during the previous quarter ended March 2025. Sales rose 38.40% to Rs 3.28 crore in the quarter ended March 2026 as against Rs 2.37 crore during the previous quarter ended March 2025.

For the full year,net profit rose 70.73% to Rs 0.70 crore in the year ended March 2026 as against Rs 0.41 crore during the previous year ended March 2025. Sales rose 12.48% to Rs 15.59 crore in the year ended March 2026 as against Rs 13.86 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales3.282.37 38 15.5913.86 12
OPM %-13.72-10.97 -7.064.62 -
PBDT-0.45-0.26 -73 1.090.63 73
PBT-0.49-0.29 -69 0.950.53 79
NP-0.74-0.41 -80 0.700.41 71